My point is that there's no indication yet that any RPE trials are even enrolling. The status isn't limited to only active trials, as per the myoblast trial, 3 years on the shelf.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.